Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 1,993 | 2,069 | 2,744 | 3,064 | 5,148 |
| Gross Profit | 1,993 | 2,069 | 2,744 | 3,064 | 5,148 |
| Operating Expenses | 28,073 | 32,276 | 30,246 | 25,588 | 23,690 |
| Operating Income | -26,080 | -30,207 | -27,502 | -22,524 | -18,542 |
| Interest Expense | 117 | 2,488 | 0 | 0 | 0 |
| Other Income | -2,485 | -134 | -1,738 | 3 | -30 |
| Pre-tax Income | -28,682 | -32,829 | -29,240 | -22,521 | -18,572 |
| Net Income Continuous | -28,682 | -32,829 | -29,240 | -22,521 | -18,572 |
| Net Income | $-28,682 | $-32,829 | $-29,240 | $-22,521 | $-18,572 |
| EPS Basic Total Ops | -0.87 | -1.01 | -0.92 | -0.70 | -0.63 |
| EPS Basic Continuous Ops | -0.87 | -1.01 | -0.92 | -0.70 | -0.63 |
| EPS Diluted Total Ops | -0.87 | -1.01 | -0.92 | -0.70 | -0.63 |
| EPS Diluted Continuous Ops | -0.87 | -1.01 | -0.92 | -0.70 | -0.63 |
| EBITDA(a) | $-25,786 | $-30,018 | $-27,311 | $-22,376 | $-18,394 |